14.28
-0.46
(-3.12%)
At close: January 10 at 3:59:59 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
13,078.00
15,999.00
10,725.00
13,814.00
11,691.00
Investing Cash Flow
-80,181.00
-144.00
-81.00
--
-760.00
Financing Cash Flow
34,459.00
-5,244.00
-1,912.00
-2,470.00
-8,132.00
Cash Flow from Discontinued Operation
--
--
--
--
-1.00
End Cash Position
9,442.00
39,825.00
28,836.00
20,548.00
9,142.00
Capital Expenditure
--
-144.00
-81.00
--
-760.00
Issuance of Capital Stock
--
--
--
--
38.00
Repayment of Debt
--
--
-58.00
-828.00
-7,929.00
Repurchase of Capital Stock
-5,277.00
-5,559.00
-1,988.00
-1,717.00
-78.00
Free Cash Flow
12,897.00
15,855.00
10,644.00
13,814.00
10,931.00
12/31/2020 - 5/7/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HASH.V SIMPLY SOLVENTLESS CONCENTRATES
0.7000
+1.45%
GUD.TO Knight Therapeutics Inc.
5.34
-2.73%
MOB.ST Moberg Pharma AB (publ)
9.36
-4.00%
RX.V BioSyent Inc.
11.17
-2.27%
MDP.TO Medexus Pharmaceuticals Inc.
4.0400
-0.74%
SBBC.V Simply Better Brands Corp.
1.0800
-0.92%
CTX.TO Crescita Therapeutics Inc.
0.5700
-3.39%
CRON.TO Cronos Group Inc.
2.8300
0.00%
BHC.TO Bausch Health Companies Inc.
11.38
-1.98%
TSND.TO TerrAscend Corp.
0.7900
-5.95%